Illumina, Icahn prepare for proxy showdown
BioPharma
Stay updated with breaking news from Icahn Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The proxy fight between billionaire activist investor Carl Icahn and Illumina (ILMN) is getting more heated. The biotech firm's board told investors not to…
Biotech firm Illumina (ILMN) told shareholders not to vote for the board nominees put forward by billionaire activist investor Carl Icahn.
/PRNewswire/ -- Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the...
Introduction The following discussion and analysis presents management's view of our business, financial condition and overall performance and should be read in conjunction with our Consolidated... | February 23, 2023